CIK: 1284839 - Address: C/O Maxcyte, Inc., 9713 Key West Avenue, Suite 400, Rockville, MD 20850
7 results

TC

Stat

Stk

Ins

Fil

+d

+w

+m

+q

+h

+y

avg

P%ret11621716318
P%wins67678367678372

Filing Date

T Date

Ticker

Issuer

Inc

Sector

Ind

Industry

Owner

oSt

Rel

Title

T

TVal

Price

L

Qty

oc

Own

H

r2y

r1y

r6m

r3m

r6w

r3w

r7d

r3d

f1d

f1w

f1m

f3m

f6m

f1y

5/21/20 16:31
5/20/20
OXFDOxford Immunotec Global PlcX0HealthDiagnIn Vitro & In Vivo DiagnosticBalthrop Patrick JX0DP5012.4804New4D
3/2/10 16:53
11/13/09
LMNXLuminex CorpDEHealthMdEqSurgical & Medical InstrumentBalthrop Patrick JTXDOP,CEOP.a9313.23372397D-15-9-49-2504141010-321
11/16/09 11:47
11/13/09
LMNXLuminex CorpDEHealthMdEqSurgical & Medical InstrumentBalthrop Patrick JTXDOP,CEOP9313.23672383D-18-44-15-14-22-17-1114510132927
5/9/05 16:05
5/6/05
LMNXLuminex CorpDEHealthBiolabCommercial Physical & BiologiBalthrop Patrick JTXDOP,CEOP1338.901156250D43-931318201110-2-11-43789
8/5/04 17:25
8/5/04
LMNXLuminex CorpDEHealthBiolabCommercial Physical & BiologiBalthrop Patrick JTXOP,CEOP717.081104235D1244-43-24-28-15-3-4-6-810121151
5/21/04 16:26
5/20/04
LMNXLuminex CorpDEHealthBiolabCommercial Physical & BiologiBalthrop Patrick JTXOP,CEOP649.14173210D40540-71-5-9-13967-17-8-6
5/20/04 16:46
5/19/04
LMNXLuminex CorpDEHealthBiolabCommercial Physical & BiologiBalthrop Patrick JTXOP,CEOP3010.00132203D61751210851005109-1504

DDerivative transaction in filing (usually option exercise)
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
AAmended filing
EError detected in filing
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top

Contact